FBC
SGEN

Fairfield, Bush & Co’s Seagen Inc. Common Stock SGEN Stock Holding History

Fairfield, Bush & Co’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-90
Closed -$20.6K – 527
2023
Q4 		$20.6K Sell
90
-6,279
-99% -$1.35M 0.01% 253
2023
Q3 		$1.35M Sell
6,369
-13,000
-67% -$2.6M 0.88% 33
2023
Q2 		$3.73M Buy
19,369
+1,728
+10% +$343K 1.03% 22
2023
Q1 		$3.57M Buy
17,641
+10,615
+151% +$1.7M 1.26% 23
2022
Q4 		$903K Sell
7,026
-2,236
-24% -$289K 0.6% 41
2022
Q3 		$1.27M Buy
9,262
+1,610
+21% +$262K 0.89% 30
2022
Q2 		$1.35M Sell
7,652
-1,458
-16% -$210K 0.8% 30
2022
Q1 		$1.31M Sell
9,110
-490
-5% -$66.3K 0.66% 39
2021
Q4 		$1.48M Sell
9,600
-11,472
-54% -$1.92M 0.71% 36
2021
Q3 		$3.58M Sell
21,072
-780
-4% -$121K 1.16% 26
2021
Q2 		$3.45M Sell
21,852
-323
-1% -$48K 0.94% 35
2021
Q1 		$3.08M Buy
22,175
+7,140
+47% +$1.15M 0.88% 34
2020
Q4 		$2.63M Buy
15,035
+2,515
+20% +$469K 0.77% 36
2020
Q3 		$2.45M Buy
12,520
+1,407
+13% +$236K 0.78% 34
2020
Q2 		$1.89M Sell
11,113
-225
-2% -$33.6K 0.67% 40
2020
Q1 		$1.31M Buy
11,338
+100
+0.9% +$11.1K 0.54% 42
2019
Q4 		$1.28M Sell
11,238
-262
-2% -$27.8K 0.47% 50
2019
Q3 		$982K Hold
11,500
– – 0.34% 64
2019
Q2 		$796K Sell
11,500
-400
-3% -$28K 0.27% 77
2019
Q1 		$872K Sell
11,900
-550
-4% -$39.1K 0.29% 72
2018
Q4 		$705K Hold
12,450
– – 0.24% 81
2018
Q3 		$960K Sell
12,450
-200
-2% -$14.7K 0.27% 74
2018
Q2 		$840K Sell
12,650
-3,500
-22% -$200K 0.25% 75
2018
Q1 		$845K Sell
16,150
-622
-4% -$33.9K 0.25% 75
2017
Q4 		$897K Hold
16,772
– – 0.25% 73
2017
Q3 		$913K Hold
16,772
– – 0.29% 66
2017
Q2 		$868K Hold
16,772
– – 0.28% 65
2017
Q1 		$1.05M Hold
16,772
– – 0.33% 54
2016
Q4 		$885K Sell
16,772
-1,400
-8% -$84.2K 0.29% 62
2016
Q3 		$981K Sell
18,172
-3,650
-17% -$173K 0.32% 58
2016
Q2 		$882K Buy
21,822
+150
+0.7% +$5.71K 0.31% 58
2016
Q1 		$760K Buy
21,672
+1,500
+7% +$50.4K 0.27% 63
2015
Q4 		$905K Buy
20,172
+4,900
+32% +$204K 0.32% 63
2015
Q3 		$589K Sell
15,272
-1,325
-8% -$59.7K 0.26% 69
2015
Q2 		$803K Sell
16,597
-25
-0.2% -$1.03K 0.24% 81
2015
Q1 		$588K Buy
16,622
+300
+2% +$10.2K 0.17% 100
2014
Q4 		$524K Sell
16,322
-240
-1% -$8.37K 0.15% 108
2014
Q3 		$616K Buy
16,562
+3,015
+22% +$119K 0.18% 102
2014
Q2 		$518K Buy
13,547
+7,250
+115% +$274K 0.15% 107
2014
Q1 		$287K Buy
+6,297
New +$301K 0.14% 88

Fairfield, Bush & Co's SGEN Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Seagen Inc. Common Stock (SGEN) in Q1 2024, closing a stake of 90 shares — an estimated $20.6K sold.

Fairfield, Bush & Co first reported a position in SGEN in Q1 2014 and held it in 40 quarters. The position peaked at $3.73M in Q2 2023. 0 funds tracked by Wall St. Rank hold SGEN as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining Seagen Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 90 Seagen Inc. Common Stock shares in Q1 2024, an estimated $20.6K.
  • Fairfield, Bush & Co first reported a position in Seagen Inc. Common Stock in Q1 2014 and held it in 40 quarters.
  • Fairfield, Bush & Co's Seagen Inc. Common Stock position peaked at $3.73M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.